ATE277012T1 - Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress - Google Patents
Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stressInfo
- Publication number
- ATE277012T1 ATE277012T1 AT99945671T AT99945671T ATE277012T1 AT E277012 T1 ATE277012 T1 AT E277012T1 AT 99945671 T AT99945671 T AT 99945671T AT 99945671 T AT99945671 T AT 99945671T AT E277012 T1 ATE277012 T1 AT E277012T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- donor
- stress
- piperidine
- nitrogen oxide
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 7
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical class C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 1
- -1 superoxide ion Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002840 nitric oxide donor Substances 0.000 abstract 2
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 239000002516 radical scavenger Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801398.0A GB9801398D0 (en) | 1998-01-22 | 1998-01-22 | Chemical compounds |
PCT/GB1999/000231 WO1999037616A1 (en) | 1998-01-22 | 1999-01-22 | Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE277012T1 true ATE277012T1 (de) | 2004-10-15 |
Family
ID=10825732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99945671T ATE277012T1 (de) | 1998-01-22 | 1999-01-22 | Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress |
Country Status (9)
Country | Link |
---|---|
US (3) | US6448267B1 (de) |
EP (1) | EP1124801B1 (de) |
JP (1) | JP2002501049A (de) |
AT (1) | ATE277012T1 (de) |
AU (1) | AU4120699A (de) |
CA (1) | CA2318208C (de) |
DE (1) | DE69920496T2 (de) |
GB (1) | GB9801398D0 (de) |
WO (1) | WO1999037616A1 (de) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6310052B1 (en) | 1996-06-04 | 2001-10-30 | Queen's University At Kingston | Nitrate esters and their use for neurological conditions |
US20050137191A1 (en) * | 1996-06-04 | 2005-06-23 | Thatcher Gregory R. | Nitrate esters and their use for mitigating cellular damage |
US7914814B2 (en) * | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
US6207713B1 (en) * | 1997-09-17 | 2001-03-27 | Eric T. Fossel | Topical and oral delivery of arginine to cause beneficial effects |
US7629384B2 (en) * | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
GB2349385A (en) | 1999-04-30 | 2000-11-01 | Teijin Ltd | Organic nitrates and nitrites useful against heart disease |
US7135498B1 (en) | 1999-06-14 | 2006-11-14 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
JP2003532622A (ja) * | 1999-06-14 | 2003-11-05 | ヘンリー フォード ヘルス システム | 神経発生を誘導する一酸化窒素ドナー |
KR20010038797A (ko) * | 1999-10-27 | 2001-05-15 | 김길환 | 홍국을 이용한 일산화질소 생성제 조성물 및 이를 이용한 약품 조성물 |
SE9903985D0 (sv) * | 1999-11-03 | 1999-11-03 | Aga Ab | Use of nitric oxide |
US6601580B1 (en) * | 2000-06-28 | 2003-08-05 | The General Hospital Corporation | Enhancing therapeutic effectiveness of nitric oxide inhalation |
YU12703A (sh) * | 2000-08-22 | 2006-05-25 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg. | Farmaceutska kombinacija antagonista angiotenzina ii i inhibitora angiotenzin i konvertujućeg enzima |
US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
EP1353655A2 (de) * | 2001-01-26 | 2003-10-22 | Metaphore Pharmaceuticals Inc. | Verfahren zur behandlung von neurodegenerativen erkrankungen mit pentaaza-makrozyklischen ligandkomplexen |
US20020151431A1 (en) * | 2001-01-26 | 2002-10-17 | Jeff Thornton | Recovery method |
US20030045461A1 (en) | 2001-09-06 | 2003-03-06 | Jen-Chang Hsia | Composition and methods of esterified nitroxides gated with carboxylic acids |
WO2003053425A1 (en) * | 2001-12-10 | 2003-07-03 | Yansheng Du | Treatment of neurodegenerative and cardiovascular disorders |
US7378438B2 (en) | 2002-04-19 | 2008-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
AU2003229016A1 (en) * | 2002-05-10 | 2003-11-11 | The Trustees Of Columbia University In The City Of New York | Genetically engineered cell lines and systems for propagatingvaricella zoster virus and methods of use thereof |
AU2003278565A1 (en) * | 2002-10-25 | 2004-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
WO2004047837A2 (en) * | 2002-11-22 | 2004-06-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-blockers having antioxidant and nitric oxide-donor activity |
US20060166894A1 (en) * | 2002-11-29 | 2006-07-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Ace-inhibitors having antioxidant and no-donor activity |
WO2004078172A2 (en) * | 2003-03-06 | 2004-09-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sod mimic multifunctional compounds for treating inflammatory bowel disease |
CA2556967A1 (en) * | 2004-02-23 | 2005-09-09 | Strategic Science & Technologies, Llc | Topical delivery of a nitric oxide donor to improve body and skin appearance |
WO2005102282A1 (en) | 2004-04-19 | 2005-11-03 | Strategic Science & Technologies, Llc | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
US20110028548A1 (en) * | 2004-04-19 | 2011-02-03 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
US20090105336A1 (en) * | 2004-04-19 | 2009-04-23 | Strategic Science & Technologies, Llc | Beneficial Effects of Increasing Local Blood Flow |
AU2005250056A1 (en) | 2004-06-03 | 2005-12-15 | Athlomics Pty Ltd | Agents and methods for diagnosing stress |
US20070254900A1 (en) * | 2004-08-11 | 2007-11-01 | Kassab Ghassan S | Treatments for Congestive Heart Failure |
WO2006037050A2 (en) * | 2004-09-24 | 2006-04-06 | Metaphore Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
WO2006084041A2 (en) | 2005-02-02 | 2006-08-10 | Mitos Pharmaceuticals, Inc. | Nitroxides for use in treating or preventing diabetes |
WO2006084200A2 (en) * | 2005-02-02 | 2006-08-10 | Mitos Pharmaceuticals, Inc. | Nitroxides for use in treating or preventing cardiovascular disease |
US20090042819A1 (en) * | 2005-02-16 | 2009-02-12 | Nitromed, Inc. | Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
AU2006223392A1 (en) * | 2005-03-09 | 2006-09-21 | Nicox S.A. | Organic nitric oxide enhancing salts of angiotensin II antagonists, compositions and methods of use |
WO2006127591A2 (en) * | 2005-05-23 | 2006-11-30 | Nitromed, Inc. | Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
EP1888510A4 (de) | 2005-05-27 | 2013-01-16 | Univ North Carolina | Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen |
EP1933845A2 (de) | 2005-08-25 | 2008-06-25 | Medtronic Vascular, Inc. | Stickoxid freisetzende biologisch abbaubare polymere als medizinprodukte und beschichtungen dafür |
WO2007075541A2 (en) * | 2005-12-20 | 2007-07-05 | Nitromed, Inc. | Nitric oxide enhancing glutamic acid compounds, compositions and methods of use |
WO2007075542A2 (en) * | 2005-12-22 | 2007-07-05 | Nitromed, Inc. | Nitric oxide enhancing pyruvate compounds, compositions and methods of use |
MX2008014396A (es) * | 2006-05-11 | 2009-02-06 | Textron Innovations Inc | Dispositivo y metodo para reparar componentes estructurales. |
US7985594B2 (en) * | 2006-05-12 | 2011-07-26 | Massachusetts Institute Of Technology | Biradical polarizing agents for dynamic nuclear polarization |
WO2007134160A2 (en) * | 2006-05-12 | 2007-11-22 | Massachusetts Institute Of Technology | Temperature-jump dynamic nuclear polarization |
US8241619B2 (en) | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
JP5191702B2 (ja) * | 2006-08-01 | 2013-05-08 | 三菱レイヨン株式会社 | N−オキシル化合物、その製造方法および重合防止方法 |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
US8273828B2 (en) * | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
US20090222088A1 (en) * | 2008-02-29 | 2009-09-03 | Medtronic Vascular, Inc. | Secondary Amine Containing Nitric Oxide Releasing Polymer Composition |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
US20120245080A1 (en) | 2009-04-15 | 2012-09-27 | Bmg Pharma Llc | Mineral salt-sulfonic acid compositions and methods of use |
BRPI0925099A2 (pt) | 2009-06-24 | 2018-10-16 | Strategic Science & Tech Llc | composição tópica contendo ibuprofeno |
EP2445493A1 (de) | 2009-06-24 | 2012-05-02 | Strategic Science & Technologies, LLC | Topische zusammensetzung mit naproxen |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
BR112012003804B1 (pt) | 2009-08-21 | 2019-02-19 | Novan, Inc. | Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento |
CN102711729B (zh) | 2009-08-21 | 2015-04-01 | 诺万公司 | 局部用凝胶 |
EP2528601A1 (de) * | 2010-01-26 | 2012-12-05 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Zusammensetzungen und verfahren zur prävention und behandlung von lungenhochdruck |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
US9289495B2 (en) | 2010-12-29 | 2016-03-22 | Strategic Science & Technologies, Llc | Systems and methods for treatment of allergies and other indications |
JP2014504592A (ja) | 2010-12-29 | 2014-02-24 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 勃起不全および他の適応症の処置 |
WO2012093383A1 (en) | 2011-01-04 | 2012-07-12 | Radikal Therapeutics Inc. | Compositions and methods for treatment of sepsis and related conditions |
EP2681286B1 (de) | 2011-02-28 | 2018-08-15 | Novan, Inc. | Stickoxid-freisetzende s-nitrosothiol-modifizierte kieselsäureteilchen und verfahren zu ihrer herstellung |
WO2013005216A1 (en) * | 2011-07-05 | 2013-01-10 | Radikal Therapeutics Inc. | Compositions and methods for treatment of renal ischemia-reperfusion injury |
US8715621B2 (en) | 2012-03-15 | 2014-05-06 | Massachusetts Institute Of Technology | Radical polarizing agents for dynamic nuclear polarization |
US20150368197A1 (en) | 2012-06-21 | 2015-12-24 | Radikal Therapeutics Ins. | Compositions and methods for treatment of inflammatory diseases of the lung |
US9604932B2 (en) | 2013-03-05 | 2017-03-28 | Radikal Therapeutics Inc. | Substituted 1-pyrrolidinyloxy, 1-piperidinyloxy and 1-azepanyloxy compounds for treating diseases associated with oxidative stress or endothelial dysfunction |
CN107847484B (zh) * | 2015-03-26 | 2021-07-06 | 耶路撒冷希伯来大学伊森姆研究发展公司 | 用于治疗呼吸道疾病的硝基氧自由基 |
CA3204594A1 (en) | 2020-12-15 | 2022-06-23 | Life Technologies Corporation | Chemically defined serum albumin substitutes |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3752812A (en) | 1970-02-05 | 1973-08-14 | Pfizer | 2-trifluoromethylquinoxalinedi n oxides |
US4563446A (en) | 1983-07-27 | 1986-01-07 | Takeda Chemical Industries, Ltd. | Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines |
DE3328365A1 (de) * | 1983-08-03 | 1985-02-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue diagnostische mittel |
US5352442A (en) | 1985-07-18 | 1994-10-04 | Proctor Peter H | Topical tempo |
US5890387A (en) | 1989-08-24 | 1999-04-06 | Aquaform Inc. | Apparatus and method for forming and hydropiercing a tubular frame member |
IT1256450B (it) | 1992-11-26 | 1995-12-05 | Soldato Piero Del | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione |
CA2173582C (en) | 1993-10-06 | 2006-11-28 | Piero Del Soldato | Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
US6143746A (en) | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
RU2145595C1 (ru) | 1994-05-10 | 2000-02-20 | Никокс С.А. | Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности |
US5703073A (en) | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
AU6031096A (en) | 1995-06-05 | 1996-12-24 | Duke University | Nitrosylated and nitrated superoxide oxidants and reductants |
IT1276071B1 (it) | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
IT1282686B1 (it) | 1996-02-26 | 1998-03-31 | Nicox Sa | Composti in grado di ridurre la tossicita' da farmaci |
US6140309A (en) | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
US5824669A (en) | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
US5977090A (en) | 1996-09-27 | 1999-11-02 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors |
US5885842A (en) | 1996-11-08 | 1999-03-23 | Medinox, Inc. | Methods for the detection of nitric oxide in fluid media |
IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
IL120531A (en) | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
US6043252A (en) | 1997-05-05 | 2000-03-28 | Icos Corporation | Carboline derivatives |
US5916910A (en) | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
IT1292377B1 (it) | 1997-06-19 | 1999-02-08 | Nicox Sa | Composizioni farmaceutiche a base di prostaglandine |
JP3377731B2 (ja) * | 1997-09-29 | 2003-02-17 | 三菱重工業株式会社 | 高性能水素分離膜 |
AU2662799A (en) | 1998-02-13 | 1999-08-30 | Medinox, Inc. | Modified pharmacologically active agents and improved therapeutic methods employing same |
IN188837B (de) | 1998-05-22 | 2002-11-09 | Torrent Pharmaceuticals Ltd | |
US6093743A (en) | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US6265420B1 (en) | 1998-06-23 | 2001-07-24 | Medinox, Inc. | Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
EP1114048A1 (de) | 1998-09-16 | 2001-07-11 | Agnès Bombrun | Carbolin-derivate als cgmp phosphodiesterase-inhibitoren |
AU775388B2 (en) | 1998-11-25 | 2004-07-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Scavenger compounds |
CZ20012113A3 (cs) | 1998-12-14 | 2001-11-14 | Cellegy Pharmaceuticals, Inc. | Prostředky a způsoby pro léčbu onemocnění anorektální oblasti |
GB2349385A (en) | 1999-04-30 | 2000-11-01 | Teijin Ltd | Organic nitrates and nitrites useful against heart disease |
AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
BR0012793A (pt) | 1999-07-28 | 2002-04-30 | Univ Leland Stanford Junior | Métodos para indução de angiogênese pela administração de nicotina ou outro agonista de receptor de nicotina |
SE9903985D0 (sv) | 1999-11-03 | 1999-11-03 | Aga Ab | Use of nitric oxide |
-
1998
- 1998-01-22 GB GBGB9801398.0A patent/GB9801398D0/en not_active Ceased
-
1999
- 1999-01-22 AU AU41206/99A patent/AU4120699A/en not_active Abandoned
- 1999-01-22 AT AT99945671T patent/ATE277012T1/de not_active IP Right Cessation
- 1999-01-22 JP JP2000528540A patent/JP2002501049A/ja active Pending
- 1999-01-22 CA CA002318208A patent/CA2318208C/en not_active Expired - Fee Related
- 1999-01-22 US US09/600,711 patent/US6448267B1/en not_active Expired - Lifetime
- 1999-01-22 WO PCT/GB1999/000231 patent/WO1999037616A1/en active IP Right Grant
- 1999-01-22 EP EP99945671A patent/EP1124801B1/de not_active Expired - Lifetime
- 1999-01-22 DE DE69920496T patent/DE69920496T2/de not_active Expired - Lifetime
-
2002
- 2002-03-06 US US10/093,251 patent/US6455542B1/en not_active Expired - Lifetime
- 2002-07-25 US US10/205,997 patent/US6759430B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69920496T2 (de) | 2005-08-25 |
US6455542B1 (en) | 2002-09-24 |
AU4120699A (en) | 1999-08-09 |
JP2002501049A (ja) | 2002-01-15 |
CA2318208C (en) | 2009-09-29 |
EP1124801B1 (de) | 2004-09-22 |
US20030069429A1 (en) | 2003-04-10 |
US20020091266A1 (en) | 2002-07-11 |
EP1124801A1 (de) | 2001-08-22 |
DE69920496D1 (de) | 2004-10-28 |
CA2318208A1 (en) | 1999-07-29 |
US6448267B1 (en) | 2002-09-10 |
GB9801398D0 (en) | 1998-03-18 |
US6759430B2 (en) | 2004-07-06 |
WO1999037616A1 (en) | 1999-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE277012T1 (de) | Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress | |
MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
PE74399A1 (es) | Combinaciones para diabetes de sulfonilurea - glitazona | |
HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
NZ505968A (en) | Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases | |
ATE229001T1 (de) | Zwischenprodukte verwendbar in der herstellung von enzym-inhibitoren | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
EA200300792A1 (ru) | Хиназолины в качестве ингибиторов ммр-13 | |
ATE390404T1 (de) | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta | |
DE69729583D1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren | |
IL150650A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
CO5031285A1 (es) | Triarilimidazoles | |
UA35574C2 (uk) | Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі | |
DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
DE69313051D1 (de) | Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung | |
IL140070A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
DE69526917D1 (de) | Anthracyclinon-derivate und ihre verwendung in amyloidose | |
DK0882726T3 (da) | Carbazolcarboxamider som 5-HT1F-agonister | |
DE60220997D1 (de) | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält | |
NO982505L (no) | Sammensetning og fremgangsmÕte for avsvovling av gassformige eller flytende hydrokarboner, vandige systemer og blandinger derav | |
NO995594D0 (no) | Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
DE69119282T2 (de) | Aminobenzolverbindungen, Herstellung und Verwendung | |
ATE95815T1 (de) | Mittel zum schutz von pflanzen gegen krankheiten. | |
DE69312849T2 (de) | Mercapto-acetamid-derivate | |
DE60137352D1 (de) | Nsalze, verfahren zur herstellung von beiden und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |